RAFAEL HOLDINGS, INC. Construction in Progress, Gross
RAFAEL HOLDINGS, INC. (RFL) had Construction in Progress, Gross of $1.09 million as of 2019-04-30, per its 10-Q filed 2019-06-05.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:ConstructionInProgressGross · last filed 2019-10-04
- 2019-04-30: Construction in Progress, Gross $1.09M.
- 2019-01-31: Construction in Progress, Gross $1.07M.
- 2018-10-31: Construction in Progress, Gross $1.07M.
- 2018-07-31: Construction in Progress, Gross $1.02M.
| Period end | Construction in Progress, Gross |
|---|---|
| 2019-04-30 | $1.09M 10-Q · filed 2019-06-05 |
| 2019-01-31 | $1.07M 10-Q · filed 2019-03-12 |
| 2018-10-31 | $1.07M 10-Q · filed 2018-12-10 |
| 2018-07-31 | $1.02M 10-K · filed 2019-10-04 |
| 2017-07-31 | $823.00K 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |